No influence of imatinib on type 2 diabetes;Imatinib nie wpływa na przebieg cukrzycy typu 2.

Przegla̧d lekarski

Volumn 64, Issue 4-5, 2007, Pages 370-371

  Chodorowski, Zygmunt ^a   Sein Anand, Jacek ^a   Hellmann, Andrzej ^a   Prejzner, Witold ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; IMATINIB; INSULIN; METFORMIN; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC MYELOID LEUKEMIA; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; METFORMIN; MIDDLE AGED; PIPERAZINES; PYRIMIDINES;

EID: 38449104200     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)